Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

K/S APOTEKERGADE 9. HADERSLEV Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.3% 0.3%   Bankruptcy risk   0.9% 1.0% 1.0% 0.9% 5.4% 2.1% 15.5% 15.2%   Credit score (0-100)   90 87 87 88 41 66 13 13   Credit rating   A A A A BBB A BB BB   Credit limit (kDKK)   213.4 158.6 199.9 257.5 0.0 0.2 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   544 543 594 592 594 506 506 506   Gross profit   462 413 486 341 319 138 0.0 0.0   EBITDA   391 295 321 341 319 138 0.0 0.0   EBIT   391 295 321 341 -681 138 0.0 0.0   Pre-tax profit (PTP)   266.7 185.6 215.8 255.1 -767.0 -35.7 0.0 0.0   Net earnings   266.7 185.6 215.8 255.1 -767.0 -35.7 0.0 0.0   Pre-tax profit without non-rec. items   267 186 216 255 -767 -35.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   7,700 7,700 7,700 7,700 6,700 6,700 0.0 0.0   Shareholders equity total   2,647 2,833 3,048 3,304 2,537 2,501 -3,210 -3,210   Interest-bearing liabilities   4,574 4,319 4,063 3,899 3,634 3,744 3,210 3,210   Balance sheet total (assets)   7,850 7,797 7,793 7,870 7,013 6,928 0.0 0.0   Net Debt   4,424 4,223 3,974 3,794 3,333 3,557 3,210 3,210     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   544 543 594 592 594 506 506 506   Net sales growth   8.9% -0.1% 9.3% -0.3% 0.3% -14.7% 0.0% 0.0%   Gross profit   462 413 486 341 319 138 0.0 0.0   Gross profit growth   10.9% -10.7% 17.7% -29.9% -6.5% -56.7% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   7,850 7,797 7,793 7,870 7,013 6,928 0 0   Balance sheet change%   -0.2% -0.7% -0.1% 1.0% -10.9% -1.2% -100.0% 0.0%   Added value   390.7 295.5 321.0 340.8 -681.4 137.8 0.0 0.0   Added value %   71.9% 54.4% 54.0% 57.5% -114.8% 27.2% 0.0% 0.0%   Investments   0 0 0 0 -1,000 0 -6,700 0   Net sales trend   2.0 -1.0 1.0 -1.0 1.0 -1.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   71.9% 54.4% 54.0% 57.5% 53.7% 27.2% 0.0% 0.0%   EBIT %   71.9% 54.4% 54.0% 57.5% -114.8% 27.2% 0.0% 0.0%   EBIT to gross profit (%)   84.5% 71.5% 66.0% 100.0% -213.9% 100.0% 0.0% 0.0%   Net Earnings %   49.0% 34.2% 36.3% 43.1% -129.2% -7.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   49.0% 34.2% 36.3% 43.1% 39.2% -7.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   49.0% 34.2% 36.3% 43.1% -129.2% -7.0% 0.0% 0.0%   ROA %   5.0% 3.8% 4.1% 4.4% -9.2% 2.0% 0.0% 0.0%   ROI %   5.0% 3.8% 4.1% 4.4% -9.6% 2.2% 0.0% 0.0%   ROE %   10.6% 6.8% 7.3% 8.0% -26.3% -1.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   33.7% 36.3% 39.1% 42.0% 36.2% 36.1% -100.0% -100.0%   Relative indebtedness %   956.8% 913.7% 798.8% 771.1% 753.8% 874.2% 633.9% 633.9%   Relative net indebtedness %   929.2% 896.0% 783.9% 753.3% 703.2% 837.2% 633.9% 633.9%   Net int. bear. debt to EBITDA, %   1,132.3% 1,429.1% 1,238.0% 1,113.3% 1,046.2% 2,580.3% 0.0% 0.0%   Gearing %   172.8% 152.5% 133.3% 118.0% 143.3% 149.7% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.6% 2.5% 2.5% 2.2% 2.3% 4.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.5 0.3 0.3 0.6 0.7 0.3 0.0 0.0   Current Ratio   0.5 0.3 0.3 0.6 0.7 0.3 0.0 0.0   Cash and cash equivalent   149.6 96.1 88.8 105.3 300.8 187.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   27.6% 17.8% 15.7% 28.7% 52.7% 45.0% 0.0% 0.0%   Net working capital   -150.9 -190.1 -203.4 -137.7 -131.2 -464.0 -1,605.1 -1,605.1   Net working capital %   -27.7% -35.0% -34.2% -23.3% -22.1% -91.6% -317.0% -317.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0